Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?

Company Performance - Phibro Animal Health (PAHC) shares have increased by 5.2% over the past month, reaching a new 52-week high of $25.61, and have gained 120.6% since the start of the year [1] - The company reported earnings per share (EPS) of $0.35 in its last earnings report, exceeding the consensus estimate of $0.23, although it missed the revenue estimate by 6.25% [2] - For the current fiscal year, Phibro is expected to post earnings of $1.55 per share on revenues of $1.08 billion, reflecting a 31.09% change in EPS and a 6.49% change in revenues [3] Valuation Metrics - Phibro has a Value Score of A, a Growth Score of B, and a Momentum Score of D, resulting in a combined VGM Score of A [6] - The stock trades at 16.4 times the current fiscal year EPS estimates, below the peer industry average of 24.8 times, and has a PEG ratio of 0.68 [7] Zacks Rank - Phibro currently holds a Zacks Rank of 1 (Strong Buy) due to favorable earnings estimate revisions from analysts, indicating potential for further gains [8] Industry Comparison - The Medical - Products industry is performing well, ranking in the top 34% of all industries, providing a favorable environment for both Phibro and its peer, OraSure Technologies, Inc. [11]